Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
SUTRO BIOPHARMA, INC. | CEO, Director | Common Stock | 220K | $1M | $4.54 | Mar 5, 2024 | Direct |
SUTRO BIOPHARMA, INC. | CEO, Director | Restricted Stock Units (RSUs) | 167K | $758K | $4.54 | Mar 5, 2024 | Direct |
SUTRO BIOPHARMA, INC. | CEO, Director | Common Stock | 117K | $529K | $4.54 | Mar 5, 2024 | By William J. Newell Family Trust DTD 03/15/2019 |
SUTRO BIOPHARMA, INC. | CEO, Director | Restricted Stock Unit (RSU) | 18.8K | $85.1K | $4.54 | Mar 5, 2024 | Direct |
SUTRO BIOPHARMA, INC. | CEO, Director | Stock Option (Right to Buy Common Stock) | 174K | Mar 5, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
STRO | SUTRO BIOPHARMA, INC. | Mar 5, 2024 | 1 | $0 | 4/A | Mar 22, 2024 | CEO, Director |
STRO | SUTRO BIOPHARMA, INC. | Mar 5, 2024 | 5 | -$30.4K | 4 | Mar 7, 2024 | CEO, Director |
STRO | SUTRO BIOPHARMA, INC. | Mar 4, 2024 | 3 | -$53.2K | 4 | Mar 6, 2024 | CEO, Director |
STRO | SUTRO BIOPHARMA, INC. | Mar 1, 2024 | 3 | -$42.4K | 4 | Mar 5, 2024 | CEO, Director |
STRO | SUTRO BIOPHARMA, INC. | Jan 29, 2024 | 3 | -$28.1K | 4 | Jan 31, 2024 | CEO, Director |
STRO | SUTRO BIOPHARMA, INC. | Mar 3, 2023 | 7 | -$99.9K | 4 | Mar 7, 2023 | CEO, Director |
STRO | SUTRO BIOPHARMA, INC. | Jan 27, 2023 | 3 | -$42K | 4 | Jan 31, 2023 | CEO, Director |
DNAD | Social Capital Suvretta Holdings Corp. IV | Sep 7, 2022 | 0 | $0 | 3 | Sep 9, 2022 | Director |
STRO | SUTRO BIOPHARMA, INC. | Mar 14, 2022 | 1 | $77.5K | 4 | Mar 15, 2022 | CEO, Director |
STRO | SUTRO BIOPHARMA, INC. | Mar 4, 2022 | 5 | -$53K | 4 | Mar 7, 2022 | CEO, Director |
STRO | SUTRO BIOPHARMA, INC. | Jan 29, 2022 | 3 | -$54.8K | 4 | Feb 1, 2022 | CEO, Director |
STRO | SUTRO BIOPHARMA, INC. | Dec 30, 2021 | 2 | $0 | 4 | Jan 3, 2022 | CEO, Director |
STRO | SUTRO BIOPHARMA, INC. | Sep 24, 2021 | 5 | -$254K | 4 | Sep 28, 2021 | CEO, Director |